Skip to NavigationSkip to content

Richard Laxer

Published on: 06/05/22
Non-Executive Director
Oxford Science Enterprises

Richard Laxer joins Oxford Science Enterprises as an independent non-executive director. Richard is a veteran of GE Capital, serving the company for 34 years before retiring in 2018 as the CEO and Chairman. Since leaving GE Capital, Richard has used his experience and expertise to advise companies which are using cutting-edge and innovative technologies to disrupt the financial services industry.

“I am thrilled to be joining the Board of Oxford Science Enterprises,” said Richard. “The pioneering science and technology advancing from the University of Oxford has significant potential to address some of the major global impact challenges that we face today. I am excited to support the company in its investments, and to champion these new ventures into disruptive new enterprises.” 

“I am thrilled to be joining the Board of Oxford Science Enterprises,” said Richard. “The pioneering science and technology advancing from the University of Oxford has significant potential to address some of the major global impact challenges that we face today. I am excited to support the company in its investments, and to champion these new ventures into disruptive new enterprises.” 

 

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches